As a Swiss pharmaceutical manufacturer, Acino has a long history of producing oral solid dose products. We are a leader in advanced drug delivery systems with a focus on dispersible and complex modified release formulations such as Multi-Unit Pellet System (MUPS).
Every day, Acino strives to evolve its manufacturing capabilities, infrastructure and technology in order to offer best-in-class solutions to our customers as part of our ambition to be the preferred high-quality contract manufacturing and out-licensing partner, said Martin Sandgap.
Manufacturing sites: Switzerland (2), Ukraine, Estonia, and United Arab Emirates
Regional offices: Dubai, Kyiv, Johannesburg, Moscow and Panama City
Blisters in 2022
Aluminum foil used in 2022
Packs shipped in 2022
High tower of all packs shipped in 2022
Qualified suppliers in 2022
Weeks from RFQ to Offer
Transfer projects in 2022
Batch release on time
We would be delighted to meet with you at one of the following conferences.
8-10 October 2024, Fiera Milano, Italy